Preoperative Chemosensitivity Testing to Predict Treatment Benefit in Adjuvant Stage III Colon Cancer

NCT00994864 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
235
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jules Bordet Institute